Baker, B., Hoffman, C. · European Journal of Integrative Medicine · 2015
Statistically significant improvements in Total Mood Disturbance (p=0.005/0.008), anxiety (p=0.003/0.028), depression (p=0.006/0.020), and fatigue (p=0.008/0.033) occurred at both 6 and 12 weeks compared to baseline; hot flush frequency also decreased.
If findings like these hold up in larger trials, the promise is simple: a low-cost, self-administered tool that could reach people struggling with cancer & serious illness who can't easily access traditional care — at home, between appointments, or where there aren't enough clinicians to go around.
The natural next step: a head-to-head trial against an established treatment like CBT, and a larger sample to confirm the effect.
| Design | Outcome study |
|---|---|
| Participants | 41 people |
| Population | women with breast cancer receiving hormonal therapies (tamoxifen or aromatase inhibitors) experiencing side effects |
| Outcome measures | Total Mood Disturbance scale, anxiety and depression subscales, fatigue measure, menopausal symptoms/hot flush diary |
| Journal | European Journal of Integrative Medicine |
| Year | 2015 |
| Country | United Kingdom |
| Language | English |
| Method | EFT / tapping |
| Publication type | Study / trial |
| Verification | ✓ Confirmed against the primary source |
Baker, B., & Hoffman, C. (2015). Emotional Freedom Techniques (EFT) to reduce the side effects associated with tamoxifen and aromatase inhibitor use in women with breast cancer: A service evaluation. European Journal of Integrative Medicine. https://doi.org/10.1016/j.eujim.2014.10.004
This record is part of the Tapping Evidence Base — an openly-sourced, fully-referenced directory of the research on EFT/tapping. Explore more studies on Cancer & Serious Illness · Depression · Anxiety
A ready-made graphic — right-click or long-press to save the image.